期刊文献+

影响乳腺癌改良根治术后复发转移的临床病理因素分析 被引量:20

Clinical and pathological influencing factors for breast cancer recurrence and metastasis after mastectomy
下载PDF
导出
摘要 目的探讨影响乳腺癌术后局部复发与远处转移的临床病理因素。方法对比分析我院1997年5月至2005年8月收治的女性乳腺癌初治病例中术后5年内复发转移患者与5年以上无复发生存患者的临床病理资料。结果患者年龄、肿瘤组织病理类型、肿瘤大小、淋巴结转移情况、激素受体状态以及辅助化疗和内分泌治疗情况是影响乳腺癌术后复发转移的重要因素。结论乳腺癌早期诊断和规范化治疗是降低乳腺癌术后复发转移,提高生存率的关键。 Objective To discuss the clinical and pathological factors which influence breast cancer recurrence and metastasis after mastectomy. Methods The clinical and pathological data of the breast cancer patients, who underwent mastectomy in our hospital between May 1997 and August 2005, was collected. The differences between the patients whose diseases recurred and/or metastasized in 5 years after mastectomy and those who survived free of the disease more than 5 years were analyzed. Results Age, pathological type, tumor size, lymph node status, hormone receptor status adjuvant chemotherapy and endocrinotherapy were the important influencing factors. Conclusion Early diagnosis and standard therapy are key to degrade the rate of breast cancer recurrence and metastasis after mastectomy.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2007年第11期1099-1101,共3页 Journal of Third Military Medical University
关键词 乳腺癌 复发 转移 breast cancer recurrence metastasis
  • 相关文献

参考文献9

  • 1Vernon C C,Hand J W,Field S B,et al.Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer:results from five randomized controlled trials.International Collaborative Hyperthermia Group[J].Int J Radiat Oncol Boil Phys,1996,35(4):731-744.
  • 2Arriagada R,Le M G,Contesso G,et al.Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer[J].Ann Oncol,2002,13(9):1404-1413.
  • 3Fisher E R,Anderson S,Redmond C,et al.Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation:pathological findings from NSABP protocol B-06[J].Semin Surg Oncol,1992,8(3):161-166.
  • 4Fisher E R,Sass R,Fisher B,et al.Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6).Ⅱ.Relation of local breast recurrence to multicentricity[J].Cancer,1986,57(9):1717-1724.
  • 5Fisher B,Anderson S,Redmond C K,et al.Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer[J].N Engl J Med,1995,333(22):1456-1461.
  • 6Bonadonna G,Moliterni A,Zambetti M,et al.30 years' follow up of randomized studies of adjuvant CMF in operable breast cancer:cohort study[J].BMJ,2005,330(7485):217-220.
  • 7Fisher B,Fisher E R,Redmond C.Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer[J].J Clin Oncol,1986,4(6):929-941.
  • 8Fisher B,Dignam J,Bryant J,et al.Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors[J].J Natl Cancer Inst,1996,88(21):1529-1542.
  • 9Fisher B,Redmond C,Legault-Poisson S,et al.Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen:results from the National Surgical Adjuvant Breast and Bowel Project B-16[J].J Clin Oncol,1990,8(6):1005-1018.

同被引文献154

引证文献20

二级引证文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部